Review
Copyright ©The Author(s) 2021.
World J Hepatol. Oct 27, 2021; 13(10): 1269-1288
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1269
Table 1 Clinical characteristics and outcome of non-cirrhotic portal fibrosis in pediatric studies
Parameters
Prasad et al[90] (n = 45)
Sood et al[91] (n = 19)
Poddar et al[109] (n = 11)
Franchi-Abella et al[110] (n = 48)
Mean or median (range) age at presentation14.5 (6-18) yr13.8 (5.9-17.6) yr11 (5-14) yr8.75 (1 mo-16 yr)
At presentation
Variceal bleed49%15.70%54.60%18.80%
Lump upper abdomen47%84.20%45.40%43.80%
Ascites20%-18%-
Spleen size (mean) cm10.512 (4.75–17.25)8-
Variceal recurrence39%-18%-
Poor outcome
Decompensation4%0012.50%
Hepatopulmonary syndrome2%5%-4.20%
Follow-up duration (mean)48 (3-120) mo18 (2-51) mo57.5 (12-78) mo15 (1-26) yr
Survival without transplant93%100%100%88%